Mass Oral Azithromycin for Childhood Mortality: Timing of Death After Distribution in the MORDOR Trial

Clicks: 99
ID: 273346
2019
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #774 of 1,084 articles by views in clinical infectious diseases

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 1,084 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract. In a large community-randomized trial, biannual azithromycin distributions significantly reduced postneonatal childhood mortality in sub-Saharan Afric
Reference Key
c2019clinicalmass Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Porco, Travis C;Hart, John;Arzika, Ahmed M;Weaver, Jerusha;Kalua, Khumbo;Mrango, Zakayo;Cotter, Sun Y;Stoller, Nicole E;O’Brien, Kieran S;Fry, Dionna M;Vanderschelden, Benjamin;Oldenburg, Catherine E;West, Sheila K;Bailey, Robin L;Keenan, Jeremy D;Lietman, Thomas M;Macrolides Oraux pour Réduire les Décès avec un Oeil sur la Résistance (MORDOR) Study Group;
Journal clinical infectious diseases
Year 2019
DOI
DOI not found
URL
https://academic.oup.com/cid/article/68/12/2114/5250694
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.